Navigation Links
NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT)
Date:3/3/2010

The objective of the PACT program is to continue to advance cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies. Five (5) Cell Processing Facilities will support translational research in novel cell therapies, to advance the field of cellular therapy, and to enable scientifically meritorious basic science research to reach the clinical trial stage.

(PRWEB) March 3, 2010 -- On January 15, 2010, five (5) Cell Processing Facilities: Baylor College of Medicine Center for Cell and Gene Therapy, Beckman Research Institute of City of Hope, Center for Applied Technology Development, Center for Human Cell Therapy Boston, University of Minnesota, Molecular and Cellular Therapeutics Facility, The University of Wisconsin - Madison, Waisman Clinical BioManufacturing Facility and a Coordinating Center, The EMMES Corporation, were each awarded a five year contract. “We are very excited with continuing to support the cell therapy community and implementing new initiatives aimed at advancing the development of new cell therapies,” says NHLBI Project Officer Traci Heath Mondoro, PhD.


The objective of the PACT program is to continue to advance cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies. The Cell Processing Facilities will support translational research in novel cell therapies, to advance the field of cellular therapy, and to enable scientifically meritorious basic science research to reach the clinical trial stage.

This morning's announcement detailed a number of PACT’s educational initiatives, which demonstrate PACT’s commitment to the cell therapy community. These initiatives include educational web seminars, workshops and information/education sessions at upcoming scientific conferences.

Applications
PACT is currently accepting and evaluating applications. Applications for manufacturing support can be submitted through the PACT website at www.pactgroup.net.

About PACT
The PACT Group is an NHLBI-funded initiative that is committed to the advancement of effective cell therapies. PACT supports the development of novel somatic cell therapy products by providing production assistance to the cell therapy community, as well as educational training via web seminars and at meetings. Production assistance is provided through the funded contract manufacturing of therapeutic cell products at PACT processing facilities. These facilities offer scale-up capability and expertise in the translational development needed to produce cell therapy products under cGMP and cGTP regulations. PACT’s educational training focuses on: translational development/scale-up and manufacture of cell therapy products; and quality assurance and regulatory issues.

More information about PACT is available at www.pactgroup.net

Contact:
PACT, Rockville, MD
Jamie Winestone or Debbie Wood
phone: 301-251-1161

This project has been funded in whole or in part with Federal funds from the NHLBI, NIH under Contract No. HHSN268201000006C

# # #

Read the full story at http://www.prweb.com/releases/PACTGroup/CellTherapy/prweb3677854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
5. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
6. AMERIGROUP to Acquire Memphis Health Plan
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
9. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
10. Group B Strep: A Threat to Newborns That Doesnt Have to Be
11. Cynosure to Present at the Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 
(Date:2/6/2016)... St. Petersburg, FL (PRWEB) , ... February 06, 2016 , ... ... AsSeenOnTV.pro are pleased to announce the launch of a new DRTV campaign with Belly ... rug. If having tried everything from sprays to puppy pads and find nothing works, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... ... 05, 2016 , ... Successful recruitment and retention efforts, new ... initiatives have all marked the last 12 months at Roswell Park Cancer Institute ... nation’s oldest cancer center, Candace S. Johnson, PhD, outlined the many accomplishments of ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... announce the addition of micro-needling services in their Napa Valley office. The technique ... of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016  Aralez Pharmaceuticals Inc. ("Aralez") today announced the ... Tribute Pharmaceuticals Canada Inc. ("Tribute") following approval of the ... The combined company will operate under Aralez Pharmaceuticals Inc. ... Canada , Ireland ... Under the terms of the Agreement and Plan of ...
(Date:2/5/2016)... , Feb. 5, 2016  Venice,s newest laser ... the first of its kind in the area ... through advanced laser treatment. The physician-owned and operated ... Suncoast by storm with its revitalizing skin ... advanced multi-wavelength Astanza Trinity technology. http://photos.prnewswire.com/prnh/20160204/329957 ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology: